Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion
Launched by CORNERLOC · Jun 27, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how satisfied patients are after having surgery to treat sacroiliac joint dysfunction using a specific device called the TransLoc 3D SI Fusion System. The goal is to gather real-world feedback from patients who have received this treatment to understand their experiences and overall satisfaction.
To be eligible for the study, participants need to be at least 18 years old and must have had the TransLoc 3D Fusion System implanted. They should not have any other metal implants or have had their TransLoc device removed or replaced. Participants will need to be willing to take part in a survey about their satisfaction with the treatment and must have a follow-up CT scan planned at least one year after their surgery. If you decide to participate, you will share your experience through this survey, which will help improve future treatments for patients with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 year or older
- • Confirmed Implant of the Transloc 3D Fusion System
- • Did not have Transloc device removed or another manufacturer device implanted post Transloc
- • Does not have other manufacturer's titanium or metal implant
- • Patient may be included with prior allograft implant
- • Willing to participate and give written consent
- • Must have or planned CT post ≥1 year per standard of care
- Exclusion Criteria:
- • Patient is younger than 18 years
- • Patient is unable to sign the Informed Consent
- • Implant of other manufacturer's titanium or alternative metal implant
- • Revision with another manufacturer's implant
- • Fracture or unresolved trauma of implant side after implantation of TransLoc
- • Patient unwilling to participate in Patient Satisfaction Survey
- • Patient has not returned for Standard of Care follow-up
About Cornerloc
Cornerloc is a pioneering clinical trial sponsor dedicated to advancing medical research through innovative solutions and strategic partnerships. With a focus on enhancing patient outcomes and streamlining the clinical trial process, Cornerloc leverages cutting-edge technology and a patient-centric approach to facilitate efficient study design, execution, and data analysis. Committed to upholding the highest ethical standards, Cornerloc collaborates with healthcare professionals, regulatory bodies, and research institutions to drive breakthroughs in therapeutic development across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Port Charlotte, Florida, United States
Patients applied
Trial Officials
Lee James, DO
Principal Investigator
Advanced Orthopedic Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported